Gachon University Gil Medical Center

Public research footprint of Gachon University Gil Medical Center, compiled from the ClinicalTrials.gov public registry.

501

Registered studies

186

Active

Recruiting now

218

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Relapsed/Refractory Follicular Lymphoma · Pulmonary Arterial Hypertension (PAH) · COVID-19 SARS-CoV-2 Infection

Recently updated registry entries

NCT05663866 — Premedication to Reduce Amivantamab Associated Infusion Related Reactions (Active Not Recruiting)
NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Gachon University Gil Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.